Search

Your search keyword '"Guy, De Backer"' showing total 306 results

Search Constraints

Start Over You searched for: Author "Guy, De Backer" Remove constraint Author: "Guy, De Backer"
306 results on '"Guy, De Backer"'

Search Results

1. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

2. Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus – Polish multicenter study POLASPIRE

3. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

4. Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey

5. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study

6. 2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS

7. РЕКОМЕНДАЦИИ ЕВРОПЕЙСКОГО ОБЩЕСТВА КАРДИОЛОГОВ И ЕВРОПЕЙСКОГО ОБЩЕСТВА АТЕРОСКЛЕРОЗА ПО ЛЕЧЕНИЮ ДИСЛИПИДЕМИЙ

9. Potential for optimizing management of obesity in the secondary prevention of coronary heart disease

10. Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys

11. 2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

12. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

13. Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile

14. Assessing the probability of risk factor control in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey

15. Chronic medication intake in patients with stable coronary heart disease across Europe: Evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry

16. Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus – Polish multicenter study POLASPIRE

17. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

18. Evolving concepts on the management of dyslipidaemia

19. EQ-5D in coronary patients: what are they suffering from? Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry

20. The epidemiology of cardiovascular disease

21. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry

22. Dietary Sources of Fiber Intake and Its Association with Socio-Economic Factors among Flemish Preschool Children

23. Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.

24. The relation of ambulatory heart rate with all-cause mortality among middle-aged men: a prospective cohort study.

25. INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions : In Partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology

28. Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study

29. Smoking cessation in patients with established coronary artery disease : data from the POLASPIRE survey

30. Primary prevention efforts are poorly developed in people at high cardiovascular risk : A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries

31. Author response: Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

32. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test

33. Recomendações Europeias para a prevenção da doença cardiovascular na prática clínica (versão de 2012)

34. Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey

35. Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model

36. 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

38. Pharmacotherapy in patients with chronic coronary syndromes over a 20-year period (19972017)

39. EQ-5D in coronary patients: what are they suffering from? Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry

40. Prevention of cardiovascular disease: Much more is needed

41. Statin therapy in the elderly: less or more?

42. Physical Activity Status in Patients With Coronary Heart Disease: Results From the Cross-Sectional EUROASPIRE Surveys

43. The association between blood pressure and lipid levels in Europe

45. Management of dyslipidaemia in patients with coronary heart disease : results from the ESC-EORP EUROASPIRE V survey in 27 countries

46. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

47. Incidence of cardiovascular events in patients with stabilized coronary heart disease : the EUROASPIRE IV follow-up study

48. Risk factor management at the level of the individual using lifestyle changes

49. The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology

50. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia : on the need for a screening strategy in clinical practice : a report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

Catalog

Books, media, physical & digital resources